A combination of low-dose bevacizumab and imatinib enhances vascular normalisation without inducing extracellular matrix deposition.
about
A combination of low-dose bevacizumab and imatinib enhances vascular normalisation without inducing extracellular matrix deposition.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
A combination of low-dose beva ...... tracellular matrix deposition.
@en
type
label
A combination of low-dose beva ...... tracellular matrix deposition.
@en
prefLabel
A combination of low-dose beva ...... tracellular matrix deposition.
@en
P2093
P2860
P356
P1476
A combination of low-dose beva ...... tracellular matrix deposition.
@en
P2093
L M Schiffmann
M Liwschitz
M Wroblewski
P2860
P2888
P304
P356
10.1038/BJC.2017.13
P407
P577
2017-01-31T00:00:00Z
P6179
1083398185